Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Protocol for a randomized clinical trial comparing the efficacy of Structured Diet (SD) and Regular Therapy (RT) for adolescents with malnutrition having Autism Spectrum Disorder (ASD)

View through CrossRef
Background Autism spectrum disorders (ASD) have a lifelong impact on behavior, communication, cognitive function, education, physical functioning, and personal, or social life. Separate studies suggest, Therapeutic and dietary interventions are effective to some extent in managing these issues. No study integrated the nutrition and therapeutic approaches and examined the outcome on disease severity, overall health, and behavioral status in ASD. The proposed study is designed to evaluate the combined effect of regular therapy (RT) and structured diet (SD) compared to the usual diet (UD) for Adolescents with ASD. Methods The proposed study will be a randomized clinical trial (RCT) with the assessor, therapist, and participants blinded to group allocation. Seventy ASD children with malnutrition will be enrolled in two different facilities of the Centre for the Rehabilitation of the Paralysed (CRP) between January 2023 and June 2023. Participants will be enrolled through a hospital-based randomization process from a population-based screening dataset, and with a concealed group allocation to either RT+ SD or RT+ UD group with a 1:1 ratio. The outcome measures are the Childhood Autism Rating Scale as per DSM‐5 to determine the severity of ASD, Mid-upper arm circumference (MUAC), and BMI for nutritional status, and Gilliam Autism Rating Scale (GARS-2) to assess the behavioral status. Post-test will be performed after 12 weeks of intervention, and Follow-up will be taken after 6 months of post-test. Perspectives The result of the study will contribute to the provision of a comprehensive approach to malnourished Adolescents with ASD, and manage the issues related to the severity of ASD, stereotypical behavior, and anticipated health hazards. Clinical trial identifier CTRI/2022/11/047653.
Title: Protocol for a randomized clinical trial comparing the efficacy of Structured Diet (SD) and Regular Therapy (RT) for adolescents with malnutrition having Autism Spectrum Disorder (ASD)
Description:
Background Autism spectrum disorders (ASD) have a lifelong impact on behavior, communication, cognitive function, education, physical functioning, and personal, or social life.
Separate studies suggest, Therapeutic and dietary interventions are effective to some extent in managing these issues.
No study integrated the nutrition and therapeutic approaches and examined the outcome on disease severity, overall health, and behavioral status in ASD.
The proposed study is designed to evaluate the combined effect of regular therapy (RT) and structured diet (SD) compared to the usual diet (UD) for Adolescents with ASD.
Methods The proposed study will be a randomized clinical trial (RCT) with the assessor, therapist, and participants blinded to group allocation.
Seventy ASD children with malnutrition will be enrolled in two different facilities of the Centre for the Rehabilitation of the Paralysed (CRP) between January 2023 and June 2023.
Participants will be enrolled through a hospital-based randomization process from a population-based screening dataset, and with a concealed group allocation to either RT+ SD or RT+ UD group with a 1:1 ratio.
The outcome measures are the Childhood Autism Rating Scale as per DSM‐5 to determine the severity of ASD, Mid-upper arm circumference (MUAC), and BMI for nutritional status, and Gilliam Autism Rating Scale (GARS-2) to assess the behavioral status.
Post-test will be performed after 12 weeks of intervention, and Follow-up will be taken after 6 months of post-test.
Perspectives The result of the study will contribute to the provision of a comprehensive approach to malnourished Adolescents with ASD, and manage the issues related to the severity of ASD, stereotypical behavior, and anticipated health hazards.
Clinical trial identifier CTRI/2022/11/047653.

Related Results

Cognitive and ASD Symptom Profiles in Comorbid Down syndrome and Autism Spectrum Disorder
Cognitive and ASD Symptom Profiles in Comorbid Down syndrome and Autism Spectrum Disorder
Individuals with a comorbid presentation of Down syndrome (DS) and autism spectrum disorder (ASD) are a misunderstood and vulnerable group who have received little attention in the...
Disparities in autism spectrum disorder diagnoses among 8-year-old children in Colorado: Who are we missing?
Disparities in autism spectrum disorder diagnoses among 8-year-old children in Colorado: Who are we missing?
There is often a large time gap between caregivers’ initial concerns and the diagnosis of autism spectrum disorder. The current study aimed to identify factors associated with miss...
Identifying genomic risk factors for neurodevelopmental disorders using machine learning
Identifying genomic risk factors for neurodevelopmental disorders using machine learning
Neurodevelopmental disorders (NDDs) are a complex grouping of conditions arising in childhood relating to altered development and function of the brain. The primary conditions clas...
Interactions of genetic risks for autism and the broad autism phenotypes
Interactions of genetic risks for autism and the broad autism phenotypes
BackgroundCommon polygenic risk and de novo variants (DNVs) capture a small proportion of autism spectrum disorder (ASD) liability, and ASD phenotypic heterogeneity remains difficu...
44 Functional Connectivity In The Default Mode Network Of ASD and ADHD
44 Functional Connectivity In The Default Mode Network Of ASD and ADHD
Objective:Autism Spectrum Disorders (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) are neurodevelopmental disorders with overlapping symptomatology and shared genetic ma...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Therapeutic Efficacy of a Modified Ketogenic Diet in Autism Spectrum Disorder: A Randomized Controlled Trial
Therapeutic Efficacy of a Modified Ketogenic Diet in Autism Spectrum Disorder: A Randomized Controlled Trial
Abstract Background Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social communication deficits, restricted interests, and repetitive be...

Back to Top